Juan Pineda, MD
Gastroenterology · Columbia, MONPI 1386649812
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,513 and has fallen 98.6% since, to $21 in 2022.
Across 265 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$717
- Johnson & Johnson$584
- Takeda Pharmaceuticals U.S.A., Inc.$448
- Lilly USA, LLC$423
- Amarin Pharma, Inc.$408
- Novo Nordisk$369
- plus $986 from 11 others
What the payments were for
- Food & beverage$3,84898%
- Education$752%
- Entertainment$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $717 |
| Johnson & Johnson(2 entities) | 36 | $584 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $448 |
| Lilly USA, LLC | 27 | $423 |
| Amarin Pharma, Inc. | 22 | $408 |
| Novo Nordisk | 25 | $369 |
| Merck | 23 | $296 |
| Pfizer | 14 | $171 |
| AstraZeneca | 13 | $166 |
| Ironwood Pharmaceuticals, Inc | 9 | $136 |
| Boehringer Ingelheim | 9 | $134 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Bristol Myers Squibb | 1 | $13 |
| Mauna Kea Technologies, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,936 in reported general payments places this provider in the 65th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 14 | $85 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Columbia
- Bradley AndersonColumbia$194K
- Michael WilliamsColumbia$52K
- Yezaz GhouriColumbia$32K
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Kamran QureshiLake St Louis$279K
- Laith Al MomaniKansas City$249K
- Ahmed SaeedKansas City$246K
- Parakkal DeepakSaint Louis$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.